Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1935 1
1950 1
1955 1
1958 1
1960 1
1965 1
1969 2
1970 1
1971 1
1972 3
1973 2
1974 1
1975 1
1977 2
1978 4
1980 2
1981 1
1982 1
1983 3
1984 5
1985 11
1986 10
1987 8
1988 5
1989 10
1990 3
1991 2
1992 2
1993 3
1994 1
1995 5
1996 3
1997 3
1998 3
1999 2
2000 10
2001 4
2002 3
2003 2
2004 3
2005 1
2006 2
2007 4
2008 6
2009 5
2010 2
2011 2
2012 4
2013 5
2014 2
2015 2
2016 9
2017 6
2018 1
2019 2
2020 1
2021 4
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Results by year

Filters applied: . Clear all
Page 1
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group. Ridker PM, et al. N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27. N Engl J Med. 2017. PMID: 28845751 Free article. Clinical Trial.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Tornøe CW, Ryan DH; SELECT Trial Investigators. Lincoff AM, et al. N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11. N Engl J Med. 2023. PMID: 37952131 Clinical Trial.
Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C; FREEDOM Trial. Cummings SR, et al. N Engl J Med. 2009 Aug 20;361(8):756-65. doi: 10.1056/NEJMoa0809493. Epub 2009 Aug 11. N Engl J Med. 2009. PMID: 19671655 Free article. Clinical Trial.
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group. Ridker PM, et al. N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9. N Engl J Med. 2008. PMID: 18997196 Free article. Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
High-resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD.
Schwartz U, Llamazares Prada M, Pohl ST, Richter M, Tamas R, Schuler M, Keller C, Mijosek V, Muley T, Schneider MA, Quast K, Hey J, Heußel CP, Warth A, Winter H, Serçin Ö, Karmouty-Quintana H, Jyothula SS, Patel MK, Herth F, Koch I, Petrosino G, Titimeaua A, Mardin BR, Weichenhan D, Jurkowski TP, Imbusch CD, Brors B, Benes V, Jung B, Wyatt D, Stahl HF, Plass C, Jurkowska RZ. Schwartz U, et al. Among authors: stahl hf. EMBO J. 2023 Jun 15;42(12):e111272. doi: 10.15252/embj.2022111272. Epub 2023 May 5. EMBO J. 2023. PMID: 37143403 Free PMC article.
Abstracts der 3. Gemeinsamen Brachytherapiekonferenz SASRO/DEGRO/OEGRO.
Ott OJ, Strnad V, Pötter R, Hammer J, Hildebrandt G, Resch A, Kovács G, Beckmann MW, Sauer R, Niehoff P, Polgar C, Ostertag H, Major T, Eidtmann H, Jonat W, Kimmig B, Roddiger SJ, Kolotas C, Kuner RP, Martin T, Kurek R, Baltas D, Rogge B, Kautschur H, Hoffmann G, Pollow B, Kontova M, Zamboglou N, Ott O, Lotter M, Gallino A, Mahler F, Niewald M, Jafari F, Hennen B, Wisser L, Fleckenstein J, Rübe Ch, Böhm M, Micke O, Wagner W, Schäfer U, Willich N, Greiner RH, Pallas A, Pajic B, Collen T, Meurer N, Töpfer M, Ries G, Leutloff U, Frei S, Warszawski A, Baumann R, Möller T, Niedermeyer J, Karstens JH, Gripp S, Muskalla K, Pulte T, Ohmann C, Röddiger S, Dannenberg T, Tunn UW, Dimopoulos J, Schard G, Kirisits C, Lang S, Goldner G, Wachter S, Wachter-Gerstner N, Helbich T, Weise C, Bendel M, Kocher M, Müller RP, Engelmann U, Aebersold DM, Isaak B, Vetterli D, Kemmerling L, Thalmann G, Behrensmeier F, Mini R, Baier K, Wulf J, Nürnberg N, Egberts J, Galalae R, Maurer U, Maurer G, Lang K, Zumbé J, Block T, Czempiel H, Machtens S, Ponholzer A, Riedl A, Oismüller R, Somay C, Hawliczek R, Maier U, Madersbacher S, Hoinkis C, Winkler C, Lehmann D, Hakenberg O, Herrmann T, Messer PM, Gottfried HW, … See abstract for full author list ➔ Ott OJ, et al. Among authors: stahl h. Strahlenther Onkol. 2004 Jun;180 Suppl 1:109-28. doi: 10.1007/BF03356736. Strahlenther Onkol. 2004. PMID: 27137924 German. No abstract available.
Cost of dengue outbreaks: literature review and country case studies.
Stahl HC, Butenschoen VM, Tran HT, Gozzer E, Skewes R, Mahendradhata Y, Runge-Ranzinger S, Kroeger A, Farlow A. Stahl HC, et al. BMC Public Health. 2013 Nov 6;13:1048. doi: 10.1186/1471-2458-13-1048. BMC Public Health. 2013. PMID: 24195519 Free PMC article. Review.
187 results